Isabelle Paty

Residual Effects of Middle-of-the-Night Administration of Zaleplon and Zolpidem on Driving Ability, Memory Functions, and Psychomotor Performance

Joris C. Verster, Edmund R. Volkerts, A.H.C.M.L. Schreuder et al. · Journal of Clinical Psychopharmacology · 2002 · 181 citations

Medicine, Pharmacology, Pharmacotherapy +14

Efficiency and Target Derepression of Anti-miR-92a: Results of a First in Human Study

Wesley Abplanalp, Ariane Fischer, David John et al. · Nucleic Acid Therapeutics · 2020 · 151 citations

Life Sciences, Molecular Medicine, Pharmacotherapy +16

Differential Residual Effects of Zaleplon and Zopiclone on Actual Driving: a Comparison with a Low Dose of Alcohol

Annemiek Vermeeren, Wim J. Riedel, Martin P.J. van Boxtel et al. · SLEEP · 2002 · 122 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Reversibility of the anti‐FXa activity of idrabiotaparinux (biotinylated idraparinux) by intravenous avidin infusion

Isabelle Paty, Marc Trellu, J.M. Destors et al. · Journal of Thrombosis and Haemostasis · 2010 · 60 citations

Medicine, Pharmaceutics, Pharmacology +6

Residual effects of zaleplon and zolpidem following middle of the night administration five hours to one hour before awakening

Ian Hindmarch, Alain Patat, Neil Stanley et al. · Human Psychopharmacology Clinical and Experimental · 2001 · 52 citations

Medicine, Pharmacology, Pharmacotherapy +13